Literature DB >> 20645127

Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.

M Eugenia Giorgi1, Laura Ratier, Rosalía Agusti, Alberto C C Frasch, Rosa M de Lederkremer.   

Abstract

Trypanosoma cruzi, the agent of Chagas disease, expresses a unique enzyme, the trans-sialidase (TcTS) involved in the transfer of sialic acid from host glycoconjugates to mucins of the parasite. The enzyme is shed to the medium and may affect the immune system of the host. We have previously described that lactose derivatives effectively inhibited the transfer of sialic acid to N-acetyllactosamine. Lactitol also prevented the apoptosis caused by the TcTS, although it is rapidly eliminated from the circulatory system. In this paper we report covalent conjugation of polyethylene glycol (PEG) with lactose, lactobionolactone and benzyl beta-D-galactopyranosyl-(1-->6)-2-amino-2-deoxy-alpha-D-glucopyranoside (1) with the hope to improve the bioavailability, though retaining their inhibitory properties. Different conjugation methods have been used and the behavior of the PEGylated products in the TcTS reaction was studied.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645127     DOI: 10.1007/s10719-010-9300-7

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  35 in total

1.  A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.

Authors:  Sabrina Buchini; Alejandro Buschiazzo; Stephen G Withers
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

2.  In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots.

Authors:  Raghavendra Kikkeri; Bernd Lepenies; Alexander Adibekian; Paola Laurino; Peter H Seeberger
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

3.  The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.

Authors:  Alejandro Buschiazzo; María F Amaya; María L Cremona; Alberto C Frasch; Pedro M Alzari
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

Review 4.  PEG drugs: an overview.

Authors:  R B Greenwald
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

5.  A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells.

Authors:  S Schenkman; M S Jiang; G W Hart; V Nussenzweig
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

6.  Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.

Authors:  Vivechana Dixit; Jeroen Van den Bossche; Debra M Sherman; David H Thompson; Ronald P Andres
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

7.  GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli.

Authors:  Shawn DeFrees; Zhi-Guang Wang; Ruye Xing; Arthur E Scott; Jin Wang; David Zopf; Dominique L Gouty; Eric R Sjoberg; Krishnasamy Panneerselvam; Els C M Brinkman-Van der Linden; Robert J Bayer; Mads A Tarp; Henrik Clausen
Journal:  Glycobiology       Date:  2006-05-22       Impact factor: 4.313

8.  A colorimetric assay for estimation of polyethylene glycol and polyethylene glycolated protein using ammonium ferrothiocyanate.

Authors:  A Nag; G Mitra; P C Ghosh
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

9.  Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries.

Authors:  Alvaro Moncayo
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-09-08       Impact factor: 2.743

10.  Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.

Authors:  Rosalía Agustí; Gastón París; Laura Ratier; Alberto C C Frasch; Rosa M de Lederkremer
Journal:  Glycobiology       Date:  2004-04-07       Impact factor: 4.313

View more
  6 in total

Review 1.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

2.  Improved bioavailability of inhibitors of Trypanosoma cruzi trans-sialidase: PEGylation of lactose analogs with multiarm polyethyleneglycol.

Authors:  M Eugenia Giorgi; Laura Ratier; Rosalía Agusti; Alberto C C Frasch; Rosa M de Lederkremer
Journal:  Glycobiology       Date:  2012-05-30       Impact factor: 4.313

3.  Trypanosoma cruzi surface mucins are involved in the attachment to the Triatoma infestans rectal ampoule.

Authors:  María de Los Milagros Cámara; Virginia Balouz; Camila Centeno Cameán; Carmen R Cori; Gustavo A Kashiwagi; Santiago A Gil; Natalia Paula Macchiaverna; Marta Victoria Cardinal; Francisco Guaimas; Maite Mabel Lobo; Rosa M de Lederkremer; Carola Gallo-Rodriguez; Carlos A Buscaglia
Journal:  PLoS Negl Trop Dis       Date:  2019-05-20

Review 4.  trans-Sialylation: a strategy used to incorporate sialic acid into oligosaccharides.

Authors:  Rosa M de Lederkremer; María Eugenia Giorgi; Rosalía Agusti
Journal:  RSC Chem Biol       Date:  2021-11-23

5.  Oral exposure to Phytomonas serpens attenuates thrombocytopenia and leukopenia during acute infection with Trypanosoma cruzi.

Authors:  Rosiane V da Silva; Aparecida D Malvezi; Leonardo da Silva Augusto; Danielle Kian; Vera Lúcia H Tatakihara; Lucy M Yamauchi; Sueli F Yamada-Ogatta; Luiz V Rizzo; Sergio Schenkman; Phileno Pinge-Filho
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

Review 6.  Carbohydrate PEGylation, an approach to improve pharmacological potency.

Authors:  M Eugenia Giorgi; Rosalía Agusti; Rosa M de Lederkremer
Journal:  Beilstein J Org Chem       Date:  2014-06-25       Impact factor: 2.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.